The US Food and Drug Administration is “quietly working hard” to develop a regulatory framework for advanced manufacturing, according to Michael Kopcha, the director of the Office of Pharmaceutical Quality.
Speaking at the Association for Accessible Medicines’ Generics + Biosimilars conference on 8 November, Kopcha said that the program, called...